& Horne, A
GHK-Cu stimulates the release of several growth factors: VEGF (vascular endothelial growth factor) for blood vessel formation, FGF (fibroblast growth factor), NGF (nerve growth factor), and BMP-2 (bone morphogenetic protein 2) (Pickart et al., 2015)
Dosage Guidelines by Treatment Goal Acute injury recovery: 500750mcg daily for 24 weeks Chronic condition management: 250500mcg daily for 612 weeks Gut health support: 250500mcg daily for 48 weeks General wellness and prevention: 200300mcg daily, 5 days per week Important: Always consult with a healthcare provider before starting BPC-157 therapy
First characterised in receptor pharmacology studies published in the late 1990s (DOI 10.1046/j.1365-2265.1998.00629.x), ipamorelin was specifically designed to improve on the selectivity limitations of earlier GHRPs such as GHRP-2 and hexarelin, both of which produced meaningful elevations of cortisol and prolactin alongside GH stimulation
As an antioxidant, it helps protect the skin from damage caused by free radicals, contributing to a more youthful and radiant complexion